Press releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 28, 2007
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its LIVIAN™ cardiac resynchronization therapy defibrillator...
-
Dec 21, 2007TAXUS Liberte has more CE Mark-approved indications than any other drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) announced today that its TAXUS® Liberte™ paclitaxel-eluting coronary stent system has received...
-
Dec 13, 2007
Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the...
-
Nov 29, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed the recommendation of a U.S. Food and Drug Administration (FDA) advisory panel to approve...
-
Nov 28, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets Healthcare Conference, which is being held...